Peri-operative Dexmedetomidine Infusion in Pre-eclamptic Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 18, 2017

Primary Completion Date

November 1, 2018

Study Completion Date

January 1, 2019

Conditions
Pre-Eclampsia
Interventions
DRUG

placebo infusion

Caesarian section will be performed under standard general anesthesia plus pre and intra operative saline infusion (placebo) in the same rate as dexmedetomedine starting 15 minutes before induction of general anesthesia and continue till peritoneum closure.

DRUG

Dexmedetomidine infusion

Caesarian section will be performed under standard general anesthesia plus pre and intra operative Dexmedetomidine infusion in a dose of 0.5mic/kg/hour starting 15 minutes before induction of general anesthesia and continue till peritoneum closure.

Trial Locations (1)

171516

South Egypt Cancer Institute, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03391609 - Peri-operative Dexmedetomidine Infusion in Pre-eclamptic Patients | Biotech Hunter | Biotech Hunter